Overview

Point of Care Diagnostics Market is poised to value USD 79932 million by 2028 end at a CAGR of 10.8% during the forecast period 2022 to 2028.

Name: Hydroxyapatite Market: Industry Trends, Share, Size and Forecast
Brand: FutureWise Research
Price: 25.99 USD
Rating: 4.7 (43 reviews)

The POC diagnostic devices can be used in doctors' offices, hospitals, and patient's homes to provide quick feedback on a wide range of medical tests. In this context, it refers to medical diagnostic tests that are performed during or near treatment, as in, when the patient is receiving treatment. Testing was historically limited to the medical laboratory, where specimens were sent away from the point of care and findings were awaited hours or days later, during which time care was continuing without the information needed. Point of Care Diagnostics Tests covers a variety of procedures, such as blood sugar testing, blood gas analysis, electrolyte balance testing, rapid blood clotting testing, rapid cardiac marker testing, urine strip testing, pregnancy testing, screening for drugs of abuse, screening for food pathogens, screening for hemoglobin, testing for infectious diseases, testing for cholesterol, and blood pathogens. In recent years, point-of-care diagnostics have become increasingly popular. There are a number of factors that are expected to drive the market for this technology, including convenience, reduced patient wait times, fewer or no follow-ups, accurate test results, rapid patient management, and improved healthcare delivery. There are more and more patients receiving treatment in the home for acute and chronic diseases, and thus the market for Point of Care Diagnostics devices is expected to grow as a result. The market will also be boosted by increasing investments in the field of Point of Care Diagnostics. Point of care tests detects HIV rapidly, allowing rapid treatment initiation, monitoring antiretroviral therapy and drug toxicity, and detecting opportunistic infections and related diseases.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Point of Care Diagnostics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Point of Care Diagnostics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Impact of COVID-19 on Point of Care Diagnostics Market:

The University of Connecticut Health Center has developed a method based on CRISPR technology that can be used to detect diseases like COVID-19. This technology offers a highly specific, reliable and sensitive testing approach for diagnosing nuclei acid-based molecules. Furthermore, this method can be performed at room temperature, unlike the PCR-based methods, where a thermal cycler is required for maintaining temperature. But the current CRISPR detection technology requires multiple manual operations, separate amplification of nuclei acids in various reaction systems. These requirements complicate the tests, thereby risking of carrying contaminations owing to the transfer of amplified products.

Key players included in the global point-of-care diagnostics industry are:

Abbott, AccuBioTech, BioMérieux SA, Bio-Rad Laboratories, Becton, Dickinson, and Company, Chembio Diagnostics, Danaher, EKF Diagnostics, F. Hoffmann-La Roche, Instrumentation Laboratory, Johnson & Johnson, Nova, PTS Diagnostics, Sekisui Diagnostic, Siemens Healthineers, Sinocare Inc., Sysmex Corporation, Trinity Biotech, Trividia Health Inc., QIAGEN, Quidel.

Point of Care Diagnostics Market Segmentation:

By Product

• Glucose Monitoring Products
o Strips
o Meters
o Lancets & Lancing Platform
• Cardiometabolic Testing Products
o Cardia Marker Testing Products
o Blood Gas/Electrolytes Testing Products
o HBA1C Testing Products
• Infectious Disease Testing Products
o HIV testing Products
o Hepatitis C Testing Products
o Sexually Transmitted Disease (STD) Testing Products
o Healthcare-Associated Infection (HAI) Testing Products
o Respiratory Infection Testing Products
o Tropical Disease Testing Products
o Other Infectious Disease testing Products
• Coagulation Testing Products
o PT/INR Testing Products
o Activated Clotting Time (ACT/APTT) Testing Products
• Pregnancy and Fertility Testing Products
o Tumour/Cancer Marker Testing Products
o Urinalysis Testing Products
o Cholesterol Testing Products
o Hematology testing Products
o Drug-of-Abuse Testing Products
o Fecal Occult Testing Products
o Other POC Products

By Platform

Agglutination Assays
Immunoassays
Biosensors
Dipsticks
Lateral Flow Assays
Microfluidics
Molecular Diagnostics
Solid Phase

By Mode

Prescription-Based Testing
OTC Testing

By End User

Home Care/ Self Testing
Physician Offices and Outpatient Centers
Hospitals
Research Laboratories
Other End Users

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Point of Care Diagnostics Market Sample Video:

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global market by product, by platform, by mode, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com